Clinical Evaluation of a New Cancer Diagnosis Center at Kristianstad General Hospital, Sweden
18 Years
N/A
Both
Cancer
Trial Information
Clinical Evaluation of a New Cancer Diagnosis Center at Kristianstad General Hospital, Sweden
Diagnostiskt Centrum (DC), Sweden's first specialized cancer diagnosis center, was
established at Kristianstad General Hospital in 2012 as a model for reducing the time taken
to diagnose cancer in primary care patients with diffuse, non-organ specific symptoms. If it
is successful, the DC model could be rolled out to other areas of Sweden. This study by the
Center for Primary Health Care Research in Malmö, Sweden and Regionalt cancercentrum syd
will investigate whether the DC process reduces the time from (1) the point when the patient
first contacts his/her primary care center with symptoms to (2) the point when he/she is
informed about his/her diagnosis (of cancer or another disease). This will be achieved by
comparison with matched control patients with suspected cancer who will be referred to
Helsingborg General Hospital for further investigation according to existing diagnostic
procedures. Various outcome measures will be investigated, and patients' experiences of the
DC process will be assessed using a tailored questionnaire. In addition, the DC model will
be subjected to health economics analysis.
Inclusion Criteria
Individuals in two cities in southern Sweden (Helsingborg and Kristianstad) who contact
their primary care center because of diffuse, non-organ-specific symptoms
Inclusion criteria: suspicion of cancer following preliminary investigation in primary
care
Exclusion criteria: (1) age < 18 years; and (2) inability to fill in the patient
questionnaire
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Time from first contact with primary care to information on diagnosis
Outcome Description:
The time from the point at which the patient first makes contact with his/her primary care center to the point when he/she is given his/her diagnosis. This comprises two elements: (1) investigation in primary care and (2) investigation at Diagnostiskt Centrum/Helsingborg General Hospital. These two elements will be investigated as secondary outcome measures.
Outcome Time Frame:
After completion of investigation at Diagnostiskt Centrum/Helsingborg General Hospital (anticipated to be up to 37 days)
Safety Issue:
No
Principal Investigator
Jan Sundquist, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Center for Primary Health Care Research, Malmö, Sweden
Authority:
Sweden: Swedish Data Inspection Board
Study ID:
CPF-DC
NCT ID:
NCT01709539
Start Date:
October 2012
Completion Date:
October 2017
Related Keywords:
- Cancer
- Cancer diagnosis center
- Time to diagnosis
- Survival
- Health economics
- Biomarkers
Name | Location |
|---|
